|
(1) Presence of some kidney damage, as manifested by abnormal urinalysis or urine marker(s) or decreased kidney function with either elevated serum IgG or IgE or hypocomplementemia | |
(2) Abnormal renal radiologic findings: | |
(a) multiple low-density lesions on enhanced computed tomography; | |
(b) diffuse kidney enlargement; | |
(c) hypovascular solitary mass in the kidney; | |
(d) hypertrophic lesion of the renal pelvic wall without irregularities of the renal pelvic surface. | |
(3) Elevated serum IgG4 level (>135 mg/dL) | |
(4) Histological findings in the kidney: | |
(a) dense lymphoplasmacytic infiltration by >10 IgG4-positive plasma cells/high power field (HPF) and/or IgG4+/IgG+ positive plasma cells > 40%; | |
(b) characteristic (sclero-) fibrosis surrounding nests of lymphocytes and/or plasma cells; | |
(5) Histological findings in extrarenal organ(s): | |
dense lymphoplasmacytic infiltration by >10 IgG4-positive plasma cells/HPF and/or IgG4/IgG-positive plasma cells > 40% | |
Definite: (1) + (3) + (4) (a), (b) | |
(2) + (3) + (4) (a), (b) | |
(2) + (3) + (5) | |
(1) + (3) + (4) (a) + (5) | |
Probable: (1) + (4) (a), (b) | |
(2) + (4) (a), (b) | |
(2) + (5) | |
(3) + (4) (a), (b) | |
Possible: (1) + (3) | |
(2) + (3) | |
(1) + (4) (a) | |
(2) + (4) (a) | |
Appendix: | |
(1) Clinically and histologically, the following diseases should be excluded: | |
Wegener’s granulomatosis, Churg-Strauss syndrome, and extramedullary plasmacytoma. | |
(2) Radiologically, the following diseases should be excluded: | |
Malignant lymphoma, urinary tract carcinomas, renal infarction, and pyelonephritis. | |
(Rarely, Wegener’s granulomatosis, sarcoidosisand metastatic carcinoma) | |
|